ZNF672
gene geneOn this page
Also known as FLJ22301
Summary
ZNF672 (zinc finger protein 672, HGNC:26179) is a protein-coding gene on chromosome 1q44, encoding Zinc finger protein 672 (Q499Z4). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in nucleoplasm.
Source: NCBI Gene 79894 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 106 total
- MANE Select transcript:
NM_024836
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26179 |
| Approved symbol | ZNF672 |
| Name | zinc finger protein 672 |
| Location | 1q44 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ22301 |
| Ensembl gene | ENSG00000171161 |
| Ensembl biotype | protein_coding |
| Entrez | 79894 |
Gene structure
Transcript identifiers
Ensembl transcripts: 24 — 21 protein_coding, 3 protein_coding_CDS_not_defined
ENST00000306562, ENST00000423362, ENST00000428515, ENST00000502697, ENST00000505503, ENST00000510904, ENST00000515369, ENST00000906130, ENST00000906131, ENST00000906132, ENST00000906133, ENST00000906134, ENST00000906135, ENST00000906136, ENST00000906137, ENST00000906138, ENST00000906139, ENST00000906140, ENST00000906141, ENST00000933825, ENST00000943081, ENST00000943082, ENST00000943083, ENST00000943084
RefSeq mRNA: 1 — MANE Select: NM_024836
NM_024836
CCDS: CCDS1638
Canonical transcript exons
ENST00000306562 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001169362 | 248847052 | 248849517 |
| ENSE00001169681 | 248845566 | 248845662 |
| ENSE00001169686 | 248844483 | 248844636 |
| ENSE00001274553 | 248838224 | 248838551 |
Expression profiles
Bgee: expression breadth ubiquitous, 278 present calls, max score 92.46.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 22.2930 / max 216.6662, expressed in 1814 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 9656 | 9.1031 | 1729 |
| 9659 | 5.7705 | 1678 |
| 9658 | 2.9109 | 1402 |
| 9660 | 2.3182 | 1257 |
| 9657 | 1.1165 | 594 |
| 9661 | 1.0737 | 786 |
Top tissues by expression
288 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| hindlimb stylopod muscle | UBERON:0004252 | 92.46 | gold quality |
| gastrocnemius | UBERON:0001388 | 91.12 | gold quality |
| muscle of leg | UBERON:0001383 | 90.50 | gold quality |
| apex of heart | UBERON:0002098 | 90.26 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 89.21 | gold quality |
| granulocyte | CL:0000094 | 88.39 | gold quality |
| heart left ventricle | UBERON:0002084 | 87.47 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 87.44 | gold quality |
| muscle organ | UBERON:0001630 | 87.43 | gold quality |
| right atrium auricular region | UBERON:0006631 | 87.14 | gold quality |
| cardiac ventricle | UBERON:0002082 | 87.08 | gold quality |
| leukocyte | CL:0000738 | 86.18 | gold quality |
| blood | UBERON:0000178 | 86.18 | gold quality |
| monocyte | CL:0000576 | 86.14 | gold quality |
| amniotic fluid | UBERON:0000173 | 86.06 | gold quality |
| mononuclear cell | CL:0000842 | 85.97 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 85.79 | gold quality |
| cortical plate | UBERON:0005343 | 85.76 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 85.43 | gold quality |
| right lobe of liver | UBERON:0001114 | 85.35 | gold quality |
| lower esophagus | UBERON:0013473 | 85.29 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 85.28 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 85.19 | gold quality |
| heart | UBERON:0000948 | 85.01 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 84.83 | gold quality |
| ganglionic eminence | UBERON:0004023 | 84.72 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 84.64 | gold quality |
| cardiac atrium | UBERON:0002081 | 84.55 | gold quality |
| thyroid gland | UBERON:0002046 | 84.49 | gold quality |
| esophagus | UBERON:0001043 | 84.40 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.21 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2587.1 | ZNF672 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:39605368
miRNA regulators (miRDB)
27 targeting ZNF672, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6755-5P | 99.95 | 65.59 | 464 |
| HSA-MIR-4492 | 99.87 | 68.25 | 3611 |
| HSA-MIR-4428 | 99.73 | 66.41 | 1733 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-1303 | 99.65 | 69.77 | 1662 |
| HSA-MIR-4516 | 99.61 | 67.78 | 3390 |
| HSA-MIR-762 | 99.58 | 66.61 | 1994 |
| HSA-MIR-4498 | 99.47 | 67.42 | 2360 |
| HSA-MIR-940 | 99.37 | 66.14 | 2064 |
| HSA-MIR-6808-5P | 99.31 | 66.23 | 2150 |
| HSA-MIR-6893-5P | 99.31 | 66.25 | 2119 |
| HSA-MIR-544B | 99.18 | 67.41 | 1632 |
| HSA-MIR-1253 | 99.12 | 67.08 | 1688 |
| HSA-MIR-4434 | 99.10 | 67.01 | 1984 |
| HSA-MIR-5703 | 99.10 | 67.09 | 2053 |
| HSA-MIR-371A-5P | 99.08 | 66.51 | 1914 |
| HSA-MIR-5001-5P | 99.05 | 66.76 | 1972 |
| HSA-MIR-6829-5P | 98.86 | 65.12 | 1480 |
| HSA-MIR-4700-5P | 98.63 | 67.43 | 1915 |
| HSA-MIR-8089 | 97.74 | 66.21 | 1698 |
| HSA-MIR-3652 | 97.71 | 65.43 | 1890 |
| HSA-MIR-4667-5P | 97.61 | 66.67 | 1683 |
| HSA-MIR-4430 | 97.47 | 65.61 | 1813 |
| HSA-MIR-4732-3P | 97.15 | 65.45 | 881 |
| HSA-MIR-10398-5P | 97.12 | 64.94 | 1051 |
| HSA-MIR-34A-3P | 96.80 | 67.70 | 805 |
| HSA-MIR-152-5P | 96.42 | 66.59 | 960 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:dkey-14k9.3 | ENSDARG00000045595 |
| mus_musculus | Zfp672 | ENSMUSG00000049755 |
| rattus_norvegicus | Zfp672 | ENSRNOG00000002713 |
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 672 — Q499Z4 (reviewed: Q499Z4)
All UniProt accessions (3): D6RD56, D6RH11, Q499Z4
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_079112* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF13894
UniProt features (16 total): zinc finger region 14, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q499Z4-F1 | 76.42 | 0.26 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 73 (showing top):
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP, GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP, ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN, APPIERTO_RESPONSE_TO_FENRETINIDE_UP, chr1q44, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GCM_USP6, WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D, OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, BARX1_TARGET_GENES, CEBPZ_TARGET_GENES, CIITA_TARGET_GENES, FEV_TARGET_GENES, ID1_TARGET_GENES
GO Biological Process (1): regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (6): DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), sequence-specific DNA binding (GO:0043565), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (2): nucleus (GO:0005634), nucleoplasm (GO:0005654)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| DNA binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
532 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF672 | HAUS5 | O94927 | 617 |
| ZNF672 | SPMIP3 | Q5SVJ3 | 604 |
| ZNF672 | MYBPC2 | Q14324 | 512 |
| ZNF672 | PGBD2 | Q6P3X8 | 473 |
| ZNF672 | SH3BP5L | Q7L8J4 | 433 |
| ZNF672 | RAB4B | P22750 | 422 |
| ZNF672 | DESI2 | Q9BSY9 | 418 |
| ZNF672 | RFX5 | P48382 | 410 |
| ZNF672 | CCDC34 | Q96HJ3 | 386 |
| ZNF672 | GALNT16 | Q8N428 | 379 |
| ZNF672 | TP53TG3 | Q9ULZ0 | 370 |
| ZNF672 | SNRNP48 | Q6IEG0 | 369 |
| ZNF672 | CCSER1 | Q9C0I3 | 344 |
| ZNF672 | DMRTA2 | Q96SC8 | 333 |
| ZNF672 | CORO7 | P57737 | 319 |
IntAct
18 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| LIN28A | IGF2BP3 | psi-mi:“MI:0914”(association) | 0.640 |
| REPIN1 | IPO8 | psi-mi:“MI:0914”(association) | 0.640 |
| NOTCH2NLC | ZNF672 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF672 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-6 | ZNF672 | psi-mi:“MI:0915”(physical association) | 0.560 |
| REPIN1 | SET | psi-mi:“MI:0914”(association) | 0.530 |
| NOTCH2 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| REPIN1 | psi-mi:“MI:0914”(association) | 0.350 | |
| REPIN1 | POTEB | psi-mi:“MI:0914”(association) | 0.350 |
| NOTCH2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| NFIB | psi-mi:“MI:0914”(association) | 0.350 | |
| ZNF672 | NOTCH2NLC | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF672 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF672 | KRTAP10-6 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (12): ZNF672 (Affinity Capture-RNA), ZNF672 (Affinity Capture-MS), KRTAP10-6 (Two-hybrid), KRTAP2-3 (Two-hybrid), KRTAP2-4 (Two-hybrid), NOTCH2NL (Two-hybrid), NBPF19 (Two-hybrid), ZNF672 (Affinity Capture-MS), ZNF672 (Affinity Capture-MS), ZNF672 (Affinity Capture-MS), ZNF672 (Affinity Capture-MS), ZNF672 (Proximity Label-MS)
ESM2 similar proteins: A3KN32, A6NFI3, A6NM28, A8K8V0, O75467, O95201, P10075, P28698, P30373, P52736, Q07230, Q0VCC5, Q14929, Q16587, Q17QR7, Q3TDE8, Q3US17, Q499Z4, Q5RJR4, Q5T619, Q5TEC3, Q5U4E2, Q642B2, Q68H95, Q6AW86, Q6DD87, Q6PGE4, Q6ZMY9, Q6ZNH5, Q7L3S4, Q7Z7K2, Q8BI73, Q8BIF9, Q8BIQ3, Q8BJ90, Q8BKK5, Q8JZL0, Q8N393, Q8NCA9, Q96BV0
Diamond homologs: Q499Z4, Q642B2, Q99LH4, G5EFF4, O15391, O57415, O95125, O95863, P22227, P25490, P31509, Q00899, Q02026, Q02027, Q02085, Q22024, Q3B7M4, Q3TTC2, Q3UH06, Q3US17, Q504L7, Q7TSH3, Q8BI66, Q8ST83, Q8TF50, Q92618, Q92766, Q96MM3, Q99M85, Q9BV97, Q9BWW7, Q9ER74, Q9NSC2, Q9UDV6, Q6DCW1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
106 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 97 |
| Likely benign | 6 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
692 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:248844627:G:GT | donor_gain | 1.0000 |
| 1:248845555:ACT:A | acceptor_gain | 1.0000 |
| 1:248845555:ACTG:A | acceptor_gain | 1.0000 |
| 1:248845557:T:TA | acceptor_gain | 1.0000 |
| 1:248845558:G:A | acceptor_gain | 1.0000 |
| 1:248838535:G:GT | donor_gain | 0.9900 |
| 1:248838538:G:GT | donor_gain | 0.9900 |
| 1:248844631:G:GT | donor_gain | 0.9900 |
| 1:248844632:A:T | donor_gain | 0.9900 |
| 1:248845544:A:AG | acceptor_gain | 0.9900 |
| 1:248845550:T:G | acceptor_gain | 0.9900 |
| 1:248845555:A:AG | acceptor_gain | 0.9900 |
| 1:248845555:ACTGG:A | acceptor_gain | 0.9900 |
| 1:248845556:C:G | acceptor_gain | 0.9900 |
| 1:248838368:A:T | donor_gain | 0.9800 |
| 1:248838552:G:GG | donor_gain | 0.9800 |
| 1:248838552:G:GA | donor_loss | 0.9700 |
| 1:248838553:T:TC | donor_loss | 0.9700 |
| 1:248844624:A:AG | donor_gain | 0.9700 |
| 1:248844627:G:T | donor_gain | 0.9700 |
| 1:248844628:A:T | donor_gain | 0.9700 |
| 1:248845549:A:AG | acceptor_gain | 0.9700 |
| 1:248838554:GAGGG:G | donor_loss | 0.9600 |
| 1:248838827:GC:G | donor_gain | 0.9600 |
| 1:248845545:C:G | acceptor_gain | 0.9600 |
| 1:248845565:GCAC:G | acceptor_gain | 0.9500 |
| 1:248838367:G:GT | donor_gain | 0.9400 |
| 1:248842297:GTGCC:G | donor_gain | 0.9400 |
| 1:248842298:TGCCT:T | donor_gain | 0.9400 |
| 1:248839202:G:GT | donor_gain | 0.9300 |
AlphaMissense
2917 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:248848316:T:C | F348L | 1.000 |
| 1:248848318:C:A | F348L | 1.000 |
| 1:248848318:C:G | F348L | 1.000 |
| 1:248848400:T:C | F376L | 1.000 |
| 1:248848402:C:A | F376L | 1.000 |
| 1:248848402:C:G | F376L | 1.000 |
| 1:248847925:C:A | H217Q | 0.999 |
| 1:248847925:C:G | H217Q | 0.999 |
| 1:248847980:T:C | F236L | 0.999 |
| 1:248847981:T:C | F236S | 0.999 |
| 1:248847982:C:A | F236L | 0.999 |
| 1:248847982:C:G | F236L | 0.999 |
| 1:248848064:T:C | F264L | 0.999 |
| 1:248848066:C:A | F264L | 0.999 |
| 1:248848066:C:G | F264L | 0.999 |
| 1:248848148:T:C | F292L | 0.999 |
| 1:248848150:C:A | F292L | 0.999 |
| 1:248848150:C:G | F292L | 0.999 |
| 1:248848232:T:C | F320L | 0.999 |
| 1:248848234:C:A | F320L | 0.999 |
| 1:248848234:C:G | F320L | 0.999 |
| 1:248848266:G:C | R331P | 0.999 |
| 1:248848273:C:A | H333Q | 0.999 |
| 1:248848273:C:G | H333Q | 0.999 |
| 1:248848317:T:C | F348S | 0.999 |
| 1:248847923:C:A | H217N | 0.998 |
| 1:248847923:C:G | H217D | 0.998 |
| 1:248847937:C:A | H221Q | 0.998 |
| 1:248847937:C:G | H221Q | 0.998 |
| 1:248848007:C:A | H245N | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000038682 (1:248841069 T>C), RS1000358394 (1:248849310 C>T), RS1000967767 (1:248844109 A>G), RS1001336152 (1:248840981 T>C), RS1001429295 (1:248841762 A>G), RS1001452097 (1:248847153 C>T), RS1001940995 (1:248841528 C>A), RS1002236097 (1:248845361 G>T), RS1002545474 (1:248842979 C>A,T), RS1002616199 (1:248849160 G>C), RS1003009908 (1:248842304 A>C,G), RS1003592623 (1:248837943 G>C), RS1003796626 (1:248836640 T>C), RS1004079650 (1:248837000 A>G), RS1004174850 (1:248843195 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009560_3 | Decreased low contrast letter acuity in multiple sclerosis | 2.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008385 | visual acuity measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
36 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cadmium Chloride | decreases expression | 2 |
| GSK-J4 | decreases expression | 1 |
| FR900359 | decreases phosphorylation | 1 |
| TAK-243 | increases sumoylation | 1 |
| bisphenol A | decreases methylation | 1 |
| dimethylselenide | increases expression, increases oxidation | 1 |
| 2,4,5,2’,4’,5’-hexachlorobiphenyl | affects expression | 1 |
| sodium arsenite | affects cotreatment, increases abundance, increases expression | 1 |
| manganese chloride | affects cotreatment, increases abundance, increases expression | 1 |
| diallyl trisulfide | increases expression | 1 |
| beta-methylcholine | affects expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| ICG 001 | increases expression | 1 |
| abrine | increases expression | 1 |
| 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | affects cotreatment, decreases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | increases expression | 1 |
| Ethanol | affects cotreatment, decreases expression, increases abundance | 1 |
| Arsenic | increases abundance, increases expression, affects cotreatment | 1 |
| Cisplatin | increases expression | 1 |
| Demecolcine | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Estradiol | affects expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Gasoline | affects cotreatment, decreases expression, increases abundance | 1 |
| Manganese | affects cotreatment, increases abundance, increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Polycyclic Aromatic Hydrocarbons | affects cotreatment, decreases expression, increases abundance | 1 |
| Tetrachlorodibenzodioxin | affects cotreatment, decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.